Product Description
Overall, the global implantable loop recorder market was valued at over $1.3 billion in 2021. This is expected to increase over the forecast period at a CAGR of 7.9% to reach nearly $2.3 billion.
Throughout this medical market research, we analyzed global implantable loop recorded companies across more than 70 countries and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
The total number of ILR procedures was considerably impacted by COVID-19 in 2020, but was projected to recover fully in 2021, exceeding 2019 procedure levels. Aside from the decline and recovery in 2020 and 2021, associated with the delay and cancellation of elective procedures, the total number of ILR procedures is projected to grow at a mid to high single-digit rate over the forecast period.
GLOBAL IMPLANTABLE LOOP RECORDER MARKET TRENDS
The adoption of ILR devices is expected to increase as the population ages. The unit growth rates of these devices are expected to be higher in lower-income countries as healthcare becomes more accessible to people with time.
GLOBAL IMPLANTABLE LOOP RECORDER MARKET SHARE INSIGHTS
Overall, within the global ILR market the top three dominant competitors are: Medtronic, Abbott, and Boston Scientific.
In 2021, Medtronic was the leader of the implantable loop recorder market. Its products include the Reveal LINQ™ and Reveal XT™.
GLOBAL IMPLANTABLE LOOP RECORDER MARKET SEGMENTATION SUMMARY
- Implantable loop recorder market
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
